FDA Office of Compliance & Biologics Quality Issues Warning Letter to Adnan Dahdul
May 27, 2026
May 27, 2026
WASHINGTON, May 27 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Adnan Dahdul, MD from its Office of Compliance and Biologics Quality:
* * *
Recipient: Adnan Dahdul, MD, 95 Frank B Murray Street, Springfield, MA 01103, United States, adahdul@sisuhealth.com
Issuing Office: Office of Compliance and Biologics Quality, United States
WARNING LETTER
Dear Dr. Dahdul . . .
* * *
Recipient: Adnan Dahdul, MD, 95 Frank B Murray Street, Springfield, MA 01103, United States, adahdul@sisuhealth.com
Issuing Office: Office of Compliance and Biologics Quality, United States
WARNING LETTER
Dear Dr. Dahdul . . .